BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11884615)

  • 1. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.
    Shields JM; Mehta H; Pruitt K; Der CJ
    Mol Cell Biol; 2002 Apr; 22(7):2304-17. PubMed ID: 11884615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells.
    Pruitt K; Ulkü AS; Frantz K; Rojas RJ; Muniz-Medina VM; Rangnekar VM; Der CJ; Shields JM
    J Biol Chem; 2005 Jun; 280(24):23363-70. PubMed ID: 15831492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation.
    Pruitt K; Pruitt WM; Bilter GK; Westwick JK; Der CJ
    J Biol Chem; 2002 Aug; 277(35):31808-17. PubMed ID: 12082106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
    Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
    Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells.
    Gangarosa LM; Sizemore N; Graves-Deal R; Oldham SM; Der CJ; Coffey RJ
    J Biol Chem; 1997 Jul; 272(30):18926-31. PubMed ID: 9228072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras- and Raf-induced down-modulation of non-muscle tropomyosin are MEK-independent.
    Janssen RA; Veenstra KG; Jonasch P; Jonasch E; Mier JW
    J Biol Chem; 1998 Nov; 273(48):32182-6. PubMed ID: 9822696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
    Repasky GA; Zhou Y; Morita S; Der CJ
    Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells.
    Okajima E; Thorgeirsson UP
    Biochem Biophys Res Commun; 2000 Apr; 270(1):108-11. PubMed ID: 10733912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways.
    Shields JM; Rogers-Graham K; Der CJ
    J Biol Chem; 2002 Mar; 277(12):9790-9. PubMed ID: 11773051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells.
    Sheng H; Shao J; DuBois RN
    J Biol Chem; 2001 Apr; 276(17):14498-504. PubMed ID: 11278613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.
    McFall A; Ulkü A; Lambert QT; Kusa A; Rogers-Graham K; Der CJ
    Mol Cell Biol; 2001 Aug; 21(16):5488-99. PubMed ID: 11463831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.
    Su Z; Shi Y; Friedman R; Qiao L; McKinstry R; Hinman D; Dent P; Fisher PB
    Nucleic Acids Res; 2001 Apr; 29(8):1661-71. PubMed ID: 11292838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
    Fukazawa H; Uehara Y
    Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.